A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis
about
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interfaceTwo conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor.The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes.Urokinase and its receptors in chronic kidney disease.Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple SclerosisThe Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axisThe plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.Regulation of DMT1 on autophagy and apoptosis in osteoblast.Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases.Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory DiseasePlasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages.Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 geneRelationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis.Central nervous system inflammatory demyelinating diseases with stroke-like onset and their responses to thrombolysis.Increased expression of urokinase-type plasminogen activator receptor in the frontal cortex of patients with intractable frontal lobe epilepsy.The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes.Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
P2860
Q26781646-1344566A-7AD0-4F9D-BCBF-08E21BB2C69FQ33281559-F10019BC-DD23-4553-B705-60902C76416EQ33562755-8B7FDE20-3807-48D5-8958-24309BB0985DQ33629803-CBE7666C-EC98-4656-AF52-80D1F97FEB5AQ34171622-5E282198-4392-4D0F-BF32-DAE66F89ECF6Q34840113-A37BA97E-D5E1-41C5-AA53-E1226205BAD5Q35124141-3407DC99-BA45-40C8-9BFD-DA03DE372F72Q35542637-76D9F7D0-0D4F-4F20-A7AF-A76C0CE646DCQ36079853-EBA12310-7E67-4CE0-BFF6-FD283B42DE35Q36962704-FEAE995A-2351-40B7-A0F6-63B1E1C3C57CQ37366815-E4D646E0-CA31-4444-9A88-EEDD3477408EQ37725922-A87CE4CB-16FA-460E-9754-24A1D89F87DDQ37824876-B732A26A-FB88-4150-B17E-001C9024A2A2Q38919656-066E20A8-1D59-445A-A01C-A10AA61A2BB5Q38945452-D35E3601-ED80-4A93-988E-A7BEAA048676Q39013846-31CDD12D-28AE-4CBD-AF9B-CD856AC73F65Q42284657-1CEB7A7A-8985-4914-ACAF-D5BF300220C1Q43982312-AF38F5D7-1C3E-421F-8AC6-699A43CDB072Q44969161-FE1F7BE8-140D-4037-B66F-7FB6ADD7482EQ46894047-25DCF820-3775-4502-A500-8D03CDD2EA73Q48113124-46D41E07-C1CB-4CF1-8FAF-C51C45CCD993Q48117579-571859A3-2D39-4A24-A841-6A8330DC3E02Q48614461-AB4F011E-B361-43F3-8B65-690FD26EB207Q53631087-E31E2D48-4B9C-4F15-9446-EA6E30E944C9
P2860
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A role for the plasminogen act ...... tal allergic encephalomyelitis
@ast
A role for the plasminogen act ...... tal allergic encephalomyelitis
@en
type
label
A role for the plasminogen act ...... tal allergic encephalomyelitis
@ast
A role for the plasminogen act ...... tal allergic encephalomyelitis
@en
prefLabel
A role for the plasminogen act ...... tal allergic encephalomyelitis
@ast
A role for the plasminogen act ...... tal allergic encephalomyelitis
@en
P2093
P2860
P1476
A role for the plasminogen act ...... tal allergic encephalomyelitis
@en
P2093
David Baker
Djordje Gverić
Gareth Pryce
H Roger Lijnen
M Louise Cuzner
P2860
P304
P356
10.1016/S0002-9440(10)62996-3
P407
P577
2005-08-01T00:00:00Z